Zearalenone reductase from rat liver

Area of Science:

• Biochemistry
• Enzymology
• Pharmacology

Background:

• Zearalenone, a mycotoxin, is metabolized by rat liver preparations.
• This metabolism yields alpha-zearalenol, a more potent estrogenic compound.
• Understanding the enzymes involved is crucial for assessing zearalenone's biological activity.

Purpose of the Study:

• To elucidate the enzymatic features of zearalenone reductase.
• To develop a simple assay for zearalenone reductase activity.
• To characterize the properties of microsomal and cytosolic zearalenone reductases.

Main Methods:

• Development of a [3H]-zearalenone assay coupled with thin-layer chromatography (TLC).
• Characterization of enzyme activity across different pH ranges (microsomal vs. cytosolic).
• Solubilization and purification of the microsomal enzyme using Triton X-100 and multiple chromatography techniques (DEAE-Sephadex, hydroxyapatite, Sepharose 4B).

Main Results:

• Two NAD(P)H-dependent zearalenone reductases were identified: one microsomal (optimal pH 4-4.5) and one cytosolic (optimal neutral pH).
• The microsomal enzyme exclusively produced alpha-zearalenol, while the cytosolic enzyme produced both alpha- and beta-zearalenol.
• The partially purified microsomal enzyme exhibited a molecular weight of ~230,000 Da, an apparent Km of 1.0 x 10(-5) M for zearalenone, and was inhibited by high KCl concentrations but not by various metal ions or EDTA.

Conclusions:

• Rat liver microsomes and cytosol contain distinct zearalenone reductases with differing pH optima and substrate specificities.
• The microsomal zearalenone reductase has been partially purified and characterized, providing insights into its enzymatic properties.
• These findings contribute to understanding the biotransformation of zearalenone and the formation of its estrogenic metabolites.